Forsta Ap-Fonden’s Abbott Laboratories Position
Does Forsta Ap-Fonden own Abbott Laboratories (ABT)? Not currently — the last reported position was 557.1K shares worth $70M in Q4 2025; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$70M
Q4 2025
Shares
557.1K
% of Portfolio
+0.42%
Quarters Held
28
position exited
Position History ABT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q4 2025 | 557.1K | $70M | +0.42% |
| Q3 2025 | 563.2K | $75M | +0.45% |
| Q2 2025 | 516.2K | $70M | +0.46% |
| Q1 2025 | 483.7K | $64M | +0.49% |
| Q4 2024 | 421.7K | $48M | +0.34% |
| Q3 2024 | 422.1K | $48M | +0.37% |
| Q2 2024 | 383.6K | $40M | +0.35% |
| Q1 2024 | 414.3K | $47M | +0.40% |
| Q4 2023 | 446.4K | $49M | +0.50% |
| Q3 2023 | 485.6K | $47M | +0.52% |
| Q2 2023 | 472.5K | $52M | +0.55% |
| Q1 2023 | 473.8K | $48M | +0.56% |
| Q4 2022 | 524.6K | $58M | +0.65% |
| Q3 2022 | 427.6K | $41M | +0.51% |
| Q2 2022 | 357.3K | $39M | +0.51% |
| Q1 2022 | 379.8K | $45M | +0.51% |
| Q4 2021 | 379.5K | $53M | +0.54% |
| Q3 2021 | 342.7K | $40M | +0.46% |
| Q2 2021 | 332.0K | $38M | +0.45% |
| Q1 2021 | 294.0K | $35M | +0.49% |
| Q4 2020 | 333.5K | $37M | +0.55% |
| Q3 2020 | 300.4K | $33M | +0.68% |
| Q2 2020 | 261.8K | $24M | +0.63% |
| Q1 2020 | 233.1K | $18M | +0.66% |
| Q4 2019 | 40.7K | $4M | +0.18% |
| Q3 2019 | 42.7K | $4M | +0.15% |
| Q2 2019 | 45.1K | $4M | +0.17% |
| Q1 2019 | 52.3K | $4M | +0.18% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Forsta Ap-Fonden’s full portfolio or all institutional holders of ABT.